News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015
Presentation Recognition of Incident Diabetes Mellitus During an Acute MI Presenter: Suzanne V. Arnold May 06, 2015
Presentation Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With AMI Presenter: M Fujino October 20, 2014
News Daily News El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición L.A. McKeown April 11, 2014
News Daily News Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS L.A. McKeown April 11, 2014
Presentation Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes Presenter: A. Michael Lincoff April 04, 2014
News Daily News DES Outcomes Vary by Diabetes Status, Lesion Complexity Caitlin E. Cox March 13, 2014
News Daily News Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina Caitlin E. Cox October 11, 2013
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013
Presentation PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS Presenter: M. Leoncini October 09, 2013
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Conference News AHA 2012 EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES Jason Kahn November 04, 2012
News Daily News Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS July 03, 2012